Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,206 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I study of a new cancer vaccine of ten mixed peptides for advanced cancer patients.
Iwasa S, Yamada Y, Heike Y, Shoji H, Honma Y, Komatsu N, Matsueda S, Yamada A, Morita M, Yamaguchi R, Tanaka N, Kawahara A, Kage M, Shichijo S, Sasada T, Itoh K. Iwasa S, et al. Among authors: yamada y, yamada a. Cancer Sci. 2016 May;107(5):590-600. doi: 10.1111/cas.12919. Epub 2016 Apr 26. Cancer Sci. 2016. PMID: 26920496 Free PMC article. Clinical Trial.
Phase 1 clinical study of cyclophilin B peptide vaccine for patients with lung cancer.
Gohara R, Imai N, Rikimaru T, Yamada A, Hida N, Ichiki M, Kawamoto M, Matsunaga K, Ashihara J, Yano S, Tamura M, Ohkouchi S, Yamana H, Oizumi K, Itoh K. Gohara R, et al. Among authors: yamada a. J Immunother. 2002 Sep-Oct;25(5):439-44. doi: 10.1097/00002371-200209000-00008. J Immunother. 2002. PMID: 12218782 Clinical Trial.
Peptide vaccination for patients with melanoma and other types of cancer based on pre-existing peptide-specific ctotoxic T-lymphocyte precursors in the periphery.
Tanaka S, Harada M, Mine T, Noguchi M, Gohara R, Azuma K, Tamura M, Yamada A, Morinaga A, Nishikori M, Katagiri K, Itoh K, Yamana H, Hashimoto T. Tanaka S, et al. Among authors: yamada a. J Immunother. 2003 Jul-Aug;26(4):357-66. doi: 10.1097/00002371-200307000-00008. J Immunother. 2003. PMID: 12843798 Clinical Trial.
Immunological evaluation of peptide vaccination for patients with gastric cancer based on pre-existing cellular response to peptide.
Sato Y, Shomura H, Maeda Y, Mine T, Une Y, Akasaka Y, Kondo M, Takahashi S, Shinohara T, Katagiri K, Sato M, Okada S, Matsui K, Yamada A, Yamana H, Itoh K, Todo S. Sato Y, et al. Among authors: yamada a. Cancer Sci. 2003 Sep;94(9):802-8. doi: 10.1111/j.1349-7006.2003.tb01522.x. Cancer Sci. 2003. PMID: 12967479 Free PMC article. Clinical Trial.
Identification of a CTL-directed epitope encoded by an intron of the putative tumor suppressor gene Testin of the common fragile site 7G region: a peptide vaccine candidate for HLA-B52+ and HLA-62+ cancer patients.
Ohkouchi S, Kawamoto N, Koga M, Sakanashi F, Shichijo S, Saijo Y, Nukiwa T, Itoh K, Yamada A. Ohkouchi S, et al. Among authors: yamada a. Eur J Immunol. 2003 Nov;33(11):2964-73. doi: 10.1002/eji.200324149. Eur J Immunol. 2003. PMID: 14579264 Free article.
3,206 results